Bio News
Waters Corp. has launched the next-generation in vitro diagnostic (IVD) mass spectrometer Xevo TQ Absolute XR, which offers 5-fold higher sensitivity. The system features a new StepWave XR ion guide that improves robustness by up to 6-fold compared with the previous model. This will enable precise analysis with smaller sample volumes in women’s health, cancer assessment and toxicology.
BIOBOOK TEAM
biobookmedia@biobook.co.krIonkura Reports 20.8-Month Median Survival in Phase 1 Trial for Metastatic Eye Cancer
Verastem’s VS-7375 Shows Response Rates of Up to 50% in Pancreatic Cancer; Phase 3 Trial to Begin This Year
Pfizer to Co-Develop Sec61 Inhibitors With Enodia in Deal Worth Up to $500 Million
Galderma to Acquire ZO Skin Health for $1.5 Billion, Expanding Dermatology Portfolio
Verdiva halts GLP-1 transition trial, citing ‘market changes’
Stryker to Invest $400 Million in CMR Surgical, Expand Robotic Surgery
